Global Immunoglobulin Market Forecast 2022-2030
KEY FINDINGS
The global immunoglobulin market is anticipated to rise with a CAGR of 6.87% across the forecast years of 2022 to 2030. The market’s growth is strengthened by the increasing incidence of autoimmune disorders as well as immunodeficiency diseases, the rise in the geriatric populace, and the growing research and development activities.
MARKET INSIGHTS
Immunoglobulins are characterized as antibodies that are produced naturally by the body’s immune system. They primarily help fight diseases and infections. These glycoprotein molecules are generated by plasma cells and also act as a pivotal component of the immune response of the body.
The rise in the geriatric population across the world is a leading factor expected to fuel the global immunoglobulin market growth over the forecasted years. As an individual ages, their immune system tends to deteriorate and responds relatively slower. This factor significantly increases the risk of sickness.
Moreover, the loss of adaptive immunity entailing older age not only makes a person more vulnerable to infections but also reactivates dormant pathogens that were formerly suppressed. As a result, the senior population is at a higher risk of an increased incidence of immunodeficiency diseases as well as the severity of certain infections. Hence, the growth in the elderly is set to augment the prevalence of age-related diseases, subsequently increasing the need for immunoglobulin products for their treatment.
REGIONAL INSIGHTS
The global immunoglobulin market growth assessment comprises the evaluation of North America, Europe, Asia-Pacific, and Rest of World. The Asia-Pacific is expected to be the fastest-growing region during the forecast years. The regional market’s growth is mainly ascribed to the surging prevalence of different types of diseases, the increasing elderly population, and the surge in research and development.
COMPETITIVE INSIGHTS
The competitive rivalry within the global immunoglobulin market is intense and is anticipated to remain high during the forecast period. Furthermore, the presence of numerous leading market players across various regions facilitates a higher level of competition since the industry is fragmented. Some of the key players operating in the market are Pfizer Inc, Kamada Ltd, LFB Group, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Scope Of Study
- 1.3. Methodology
- 1.4. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Growth In Geriatric Population
- 3.1.2. Prevalence Of Immunodeficiency Diseases And Autoimmune Disorders
- 3.1.3. Increasing Research And Development Activities
- 3.2. Key Restraints
- 3.2.1. High Cost Of Therapy
- 3.2.2. High Risk Of Side Effects
- 4. Key Analytics
- 4.1. Impact Of Covid-19 On Immunoglobulin Market
- 4.2. Key Market Trends
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitution
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Opportunity Matrix
- 4.5. Vendor Landscape
- 4.6. Key Buying Criteria
- 4.6.1. Source
- 4.6.2. Application
- 4.6.3. Epitope
- 4.6.4. Validation
- 4.7. Regulatory Framework
- 5. Market By Product
- 5.1. Igg
- 5.2. Iga
- 5.3. Igm
- 5.4. Ige
- 5.5. Igd
- 6. Market By Mode Of Delivery
- 6.1. Intravenous Immunoglobulin
- 6.2. Subcutaneous Immunoglobulin
- 6.3. Intramuscular Immunoglobulin
- 7. Market By Application
- 7.1. Hypogamma Globulinemia
- 7.2. Chronic Inflammatory Demyelinating Polyneuropathy
- 7.3. Primary Immunodeficiency Diseases
- 7.4. Myasthenia Gravis
- 7.5. Multifocal Motor Neuropathy
- 7.6. Idiopathic Thrombocytopenic Purpura (Itp)
- 7.7. Inflammatory Myopathies
- 7.8. Specific Antibody Deficiency
- 7.9. Guillain-barre Syndrome
- 7.10. Other Applications
- 8. Market By Distribution Channel
- 8.1. Hospital Pharmacy
- 8.2. Specialty Pharmacy
- 8.3. Other Distribution Channels
- 9. Market By End-user
- 9.1. Hospitals & Clinics
- 9.2. Homecare
- 10. Geographical Analysis
- 10.1. North America
- 10.1.1. Market Size & Estimates
- 10.1.2. Key Growth Enablers
- 10.1.3. Key Challenges
- 10.1.4. Key Players
- 10.1.5. Country Analysis
- 10.1.5.1. United States
- 10.1.5.2. Canada
- 10.2. Europe
- 10.2.1. Market Size & Estimates
- 10.2.2. Key Growth Enablers
- 10.2.3. Key Challenges
- 10.2.4. Key Players
- 10.2.5. Country Analysis
- 10.2.5.1. United Kingdom
- 10.2.5.2. Germany
- 10.2.5.3. France
- 10.2.5.4. Spain
- 10.2.5.5. Italy
- 10.2.5.6. Nordic Countries
- 10.2.5.7. Rest Of Europe
- 10.3. Asia-pacific
- 10.3.1. Market Size & Estimates
- 10.3.2. Key Growth Enablers
- 10.3.3. Key Challenges
- 10.3.4. Key Players
- 10.3.5. Country Analysis
- 10.3.5.1. China
- 10.3.5.2. Japan
- 10.3.5.3. India
- 10.3.5.4. South Korea
- 10.3.5.5. Indonesia
- 10.3.5.6. Thailand
- 10.3.5.7. Vietnam
- 10.3.5.8. Australia
- 10.3.5.9. Rest Of Asia-pacific
- 10.4. Rest Of World
- 10.4.1. Market Size & Estimates
- 10.4.2. Key Growth Enablers
- 10.4.3. Key Challenges
- 10.4.4. Key Players
- 10.4.5. Regional Analysis
- 10.4.5.1. Latin America
- 10.4.5.2. Middle East & Africa
- 11. Competitive Landscape
- 11.1. Key Strategic Developments
- 11.1.1. Mergers & Acquisitions
- 11.1.2. Product Launches & Developments
- 11.1.3. Partnerships & Agreements
- 11.1.4. Business Expansions & Divestitures
- 11.2. Company Profiles
- 11.2.1. Adma Biologics
- 11.2.2. Bio Products Laboratory
- 11.2.3. Biotest Ag
- 11.2.4. China Biologic Products Inc
- 11.2.5. Csl Behring
- 11.2.6. Grifols Sa
- 11.2.7. Kamada Ltd
- 11.2.8. Kedrion Biopharma
- 11.2.9. Lfb Group
- 11.2.10. Octapharma Ag
- 11.2.11. Pfizer Inc
- 11.2.12. Sanquin Plasma Products Bv
- 11.2.13. Shanghai Raas Blood Products Co Ltd
- 11.2.14. Sichuan Yuanda Shuyang Pharmaceutical Co Ltd
- 11.2.15. Takeda Pharmaceutical Company Limited
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook